Described herein are 1,2-dioxetanes that are useful as chemiluminescent probes, diagnostic agents, and imaging agents. Also described herein are compositions containing such compounds and methods of using the same.

An apparatus, a system, sensor, and a method for determining dissolved oxygen content in air and aqueous medium are disclosed herein. The dissolved oxygen content may be determined by irradiating the sensor comprising at least a photo-oxidizable compound by a light irradiation source, wherein the irradiation enables the photo-oxidizable compound to change its luminescent properties based upon photo-oxidation thereby enabling the quantification of the dissolved oxygen content in the medium. The dissolved oxygen content may be captured via the impedance response generated by interdigitated conducting electrode patterns included in the sensor. The dissolved oxygen content registered by the interdigitated conducting electrode patterns may be transmitted to a user device via a short range or long-range communication via an electronic circuit embedded within the sensor.

An apparatus, a system, sensor, and a method for determining dissolved oxygen content in air and aqueous medium are disclosed herein. The dissolved oxygen content may be determined by irradiating the sensor comprising at least a photo-oxidizable compound by a light irradiation source, wherein the irradiation enables the photo-oxidizable compound to change its luminescent properties based upon photo-oxidation thereby enabling the quantification of the dissolved oxygen content in the medium. The dissolved oxygen content may be captured via the impedance response generated by interdigitated conducting electrode patterns included in the sensor. The dissolved oxygen content registered by the interdigitated conducting electrode patterns may be transmitted to a user device via a short range or long-range communication via an electronic circuit embedded within the sensor.

An organogold nonlinear optical chromophore includes gold(I) complexed with a benzothiazolyl-substituted fluorophore and optionally an organophosphine ligand or an N-heterocyclic carbene ligand.

An organogold nonlinear optical chromophore includes gold(I) complexed with a benzothiazolyl-substituted fluorophore and optionally an organophosphine ligand or an N-heterocyclic carbene ligand.

A composition, method, and article of manufacture are disclosed. The microcapsule includes a polymer shell encapsulating a core component. The polymer shell includes light upconversion molecules. The article of manufacture includes the microcapsule. The method includes obtaining light upconversion molecules having sidechains with reactive functional groups, and forming a microcapsule. The microcapsule includes a polymer shell encapsulating a core component. The polymer shell includes light upconversion molecules. The article of manufacture includes the microcapsule.

A composition, method, and article of manufacture are disclosed. The microcapsule includes a polymer shell encapsulating a core component. The polymer shell includes light upconversion molecules. The article of manufacture includes the microcapsule. The method includes obtaining light upconversion molecules having sidechains with reactive functional groups, and forming a microcapsule. The microcapsule includes a polymer shell encapsulating a core component. The polymer shell includes light upconversion molecules. The article of manufacture includes the microcapsule.

The present invention relates to a background blocking concept for use in time-resolved fluorometry binding assays. More particular, the invention relates to a binding assay and a kit involving the use of the same or similar chelating ligand in lanthanide chelate-labelled analyte-specific biomolecules and as or in a background blocking agent.

The present invention relates to a background blocking concept for use in time-resolved fluorometry binding assays. More particular, the invention relates to a binding assay and a kit involving the use of the same or similar chelating ligand in lanthanide chelate-labelled analyte-specific biomolecules and as or in a background blocking agent.

The present invention relates to a chemical compound comprising (i) a polycationic polymer, coupled to (ii) a dye. The present invention further relates to a method for visualizing a glycosamine-containing structure in a biological sample comprising a) contacting an inner lumen of said biological sample with a dye-conjugated polycationic polymer, preferably with the chemical compound according to the present invention; b) tissue-clearing said biological sample; and, thereby, c) visualizing an internal glycosamine-containing structure in said biological sample. The present invention also relates to a method for determining the number and/or size of glomeruli in a kidney or a sample thereof making use of the method for visualizing a glycosamine-containing structure; and also relates to kits and uses related to said chemical compounds and said methods.